Anti-coagulation therapy following coronary endarterectomy in patient with coronary artery bypass graft
- PMID: 29387316
- PMCID: PMC5771357
- DOI: 10.22088/cjim.9.1.27
Anti-coagulation therapy following coronary endarterectomy in patient with coronary artery bypass graft
Abstract
Background: Since there is a lack of research on postoperative anticoagulation protocol in patients undergoing coronary artery bypass graft (CABG) / coronary endarterectomy (CE), we recommend a new protocol for anticoagulation in these patients.
Methods: In this double-blind randomized clinical trial study, 52 patients undergoing CABG / CE entered the study and were divided into two groups. In group 1, the patients were given warfarin(international normalized ratio (INR) between 2-3) together with 80 mg aspirin daily for 3 months. In group 2, the patients were given 75 mg plavix daily together with 80 mg aspirin daily for 3 months. We evaluated patients with electrocardiography, echocardiography and checking ceratin phosphokinase MB and troponin I in the several stages. The data were analysed SPSS Version18 software.
Results: There was no significant difference between pre and post-operative Ejection fraction in patients with plavix (P=0.21) and warfarin (P=0.316) regimen. However, wall mrotion score was significantly better in clopidogrel - aspirin patients in late (3 months) post operation (p<0.001).
Conclusions: Since warfarin has serious hemorrhagic complications and requires closed monitoring of serum drug activity by serial INR checking, it is recommended that clopidogrel - aspirin can be the preferred alternative anticoagulation therapy in CABG / CE patients.
Keywords: Clopidogrel; Coronary artery bypass graft; Coronary endarterectomy; Warfarin.
Conflict of interest statement
The authors declare no conflict of interest with regard to authorship and/or publication of this article.
Figures
References
-
- Bell MR, Gersh BJ, Schaff HV, et al. Effect of completeness of revascularization on long-term outcome of patients with three-vessel disease undergoing coronary artery bypass surgery A report from the coronary artery surgery study (CASS) registry. Circulation. 1992;86:446–57. - PubMed
-
- Lawrie GM, Morris GC Jr, Silvers A, et al. The influence of residual disease after coronary bypass on the 5-year survival rate of 1274 men with coronary artery disease. Circulation. 1982;66:717–23. - PubMed
-
- Jones EL, Craver JM, Guyton RA, Bone DK, Hatcher CR Jr, Riechwald N. Importance of complete revascularization in performance of the coronary bypass operation. Am J Cardiol. 1983;51:7–12. - PubMed
-
- Bailey CP, May A, Lemmon WM. Survival after coronary endarterectomy in man. J Am Med Assoc. 1957;164:641–6. - PubMed
-
- Soylu E, Harling L, Ashrafian H, et al. Adjunct coronary endarterectomy increases myocardial infarction and early mortality after coronary artery bypass grafting: a meta-analysis. Interact Cardiovasc Thorac Surg. 2014;19:462–73. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous